Working Tirelessly to Make Health Better

We are a global health company, focused on improving the health and vitality of those we serve. Through our two divisions, Cigna HealthcareSM and Evernorth Health Services®, we are committed to enhancing the lives of our clients, customers, and patients. In order to fulfill this goal, we continually challenge ourselves to strengthen and evolve our capabilities.

View our capabilities
ENVIRONMENTAL, SOCIAL, GOVERNANCE

2023 ESG Report: A Message from David Cordani and Donna Zarcone

Our annual Environmental, Social, and Governance (ESG) Report covers activities and performance in the previous calendar-year. Read on for a message from our leadership on the launch of this year's report.

Explore the report

INVESTORS

Our growth strategy consists of our scaled businesses contributing steady, predictable growth and high-growth businesses in attractive markets combined with cross-enterprise leverage to create even greater value.

NEWSROOM

Stay up to date

SPOTLIGHT

Our Approach to Ethical AI Practices

At The Cigna GroupSM, we are committed to ethical artificial intelligence (AI) practices. Read more about how we use AI to dramatically improve the experience for all those involved in the health care journey.
Explore our AI practices
SPOTLIGHT

Four Healthcare Trends for 2023 and How They Will Impact U.S. Employers

The healthcare outlook for 2023 and beyond has a number of encouraging trends for employers who provide health insurance to employees and their families. Read on to learn about four top healthcare topics and how they will impact American businesses.
SPOTLIGHT

Video: CNBC Mad Money Interview featuring David Cordani

David Cordani, chairman and CEO of The Cigna Group, joined CNBC’s Mad Money for an interview with host Jim Cramer, where the two discussed the promise of biosimilars as well as our organization's strategy for pharmacy benefits management.
SPOTLIGHT

Cigna Offering Equal Access to New Biosimilars and HUMIRA® Next Year

As promising biosimilar therapies to treat inflammatory conditions become available next year, Cigna Pharmacy, which manages pharmacy benefits for some clients of The Cigna Group, is announcing that it will add biosimilars as preferred products on its commercial formularies at the same position as HUMIRA.

About Us

We are guided by our mission and our values and powered by our brands and over 200 years of innovation and partnership. Learn more about our commitment to the greater good on a global scale and how our past inspires our future.

Discover The Cigna Group

Our Impact

We're taking on the health care system as a whole to affect positive change. To achieve our goals, we're conducting studies with leading experts in critical areas like health equity and partnering with dynamic entrepreneurs and programs who share our vision. Through the volunteer efforts of our dedicated workforce and our philanthropic commitments, we're making a difference in the health of communities worldwide.

View our impact

Be a part of our movement.

We're looking for others who want to build a healthier future, together.

Learn More About Us

  • Environmental, Social, and Governance
  • Supplier Community
  • Media Contacts
    •

    Connect with Us on Social

    •

    © The Cigna Group

    Selecting these links will take you away from TheCignaGroup.com to another website, which may be a non-Cigna website. The Cigna Group may not control the content or links of non-Cigna websites. Details

  • Legal
  • Privacy Policy
  • Accessibility
  • Terms of Use
  • Cookie Settings
    •